MedTrace Logo

The Efficacy and Safety of Tropisetron in Preventing Emergence Delirium

NCT04027751 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1508

Last updated 2020-03-11

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy and safety of Tropisetron in preventing emergence delirium.

Conditions

  • Emergence Delirium
  • Postoperative Delirium

Interventions

DRUG

Tropisetron

Investigators administrated intravenously Tropisetron 5mg before anesthesia induction

DRUG

Placebos

Investigators administrated intravenously 0.9% saline solution as a placebo

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2021-12-31
Completion
2022-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04027751 on ClinicalTrials.gov